Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05240690
What this trial is testing

Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies

Who this might be right for
Stage IV Pancreatic CancerHepatocellular Carcinoma , Cholangiocarcinoma
Zhou Fuxiang 27
Not applicableUnknownNCT02321579
What this trial is testing

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Who this might be right for
Liver CirrhosisLiver Cancer
Taichung Veterans General Hospital 25
Not applicableActive Not RecruitingNCT06096896
What this trial is testing

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

Who this might be right for
Early Hepatocellular Carcinoma
Shandong Provincial Hospital 334
Not applicableNot Yet RecruitingNCT07667608
What this trial is testing

Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings

Who this might be right for
Cirrhosis of the LiverAscitesPleural Effusion Disorder+3 more
Assiut University 120
Not applicableLooking for participantsNCT06236568
What this trial is testing

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplant; Complications
Azienda Ospedaliero-Universitaria di Modena 40
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Not applicableStudy completedNCT05261113
What this trial is testing

CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases

Who this might be right for
Liver NeoplasmsLiver/Hepatobiliary CancerColorectal Cancer Metastatic+3 more
University of Regensburg 500
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Testing effectiveness (Phase 2)Study completedNCT01988493
What this trial is testing

Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 117
Testing effectiveness (Phase 2)Looking for participantsNCT06526104
What this trial is testing

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis, Liver
The University of Texas Health Science Center at San Antonio 32
Testing effectiveness (Phase 2)UnknownNCT05550025
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 26
Not applicableUnknownNCT05573217
What this trial is testing

The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

Who this might be right for
Cell-free Methylation Markers
National Taiwan University Hospital 180
Testing effectiveness (Phase 2)Looking for participantsNCT06420440
What this trial is testing

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Who this might be right for
HCC
Chen Xiaoping 160
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Early research (Phase 1)UnknownNCT06144385
What this trial is testing

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CarcinomaHepatic Cell Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd. 20
Not applicableWithdrawnNCT05292443
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Who this might be right for
Primary Liver CancerHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma+1 more
Geneplus-Beijing Co. Ltd.
Not applicableNot Yet RecruitingNCT07544121
What this trial is testing

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

Who this might be right for
HEPATITIS B CHRONICCirrhosis, LiverHepatocellular Carcinoma (HCC)
Nanfang Hospital, Southern Medical University 1,034
Testing effectiveness (Phase 2)UnknownNCT05240404
What this trial is testing

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Who this might be right for
Hepatocellular Carcinoma
Xiangya Hospital of Central South University 116
Not applicableStudy completedNCT04847726
What this trial is testing

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 110
Next Page